PFIZER - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.7
| Stock Code | PFIZER | Market Cap | 21,132 Cr. | Current Price | 4,625 ₹ | High / Low | 5,993 ₹ |
| Stock P/E | 27.8 | Book Value | 919 ₹ | Dividend Yield | 0.76 % | ROCE | 24.2 % |
| ROE | 18.0 % | Face Value | 10.0 ₹ | DMA 50 | 4,772 ₹ | DMA 200 | 4,899 ₹ |
| Chg in FII Hold | 0.10 % | Chg in DII Hold | -0.16 % | PAT Qtr | 193 Cr. | PAT Prev Qtr | 182 Cr. |
| RSI | 43.1 | MACD | -35.6 | Volume | 13,754 | Avg Vol 1Wk | 18,589 |
| Low price | 4,460 ₹ | High price | 5,993 ₹ | PEG Ratio | 3.45 | Debt to equity | 0.02 |
| 52w Index | 10.8 % | Qtr Profit Var | -2.64 % | EPS | 158 ₹ | Industry PE | 31.6 |
📊 Optimal Buy Price (Intraday): ₹4,600–4,630 (near support zone, below 50 DMA at ₹4,772)
🎯 Profit-Taking Levels: ₹4,700–4,750 (short-term resistance zone, below 200 DMA at ₹4,899)
🛡️ Stop-Loss / Loss Protection: ₹4,560–4,570 (below intraday support zone)
⏱️ Exit Strategy (If Already Holding): Exit if price fails to sustain above ₹4,570 with weakening volume, or book profits if RSI approaches 46–48 and momentum flattens. Extend trades only if breakout above ₹4,750 is confirmed with strong intraday volume.
---
### Positive
- EPS at ₹158 reflects strong profitability.
- ROCE (24.2%) and ROE (18.0%) indicate solid efficiency.
- Dividend yield at 0.76% adds investor appeal.
- Debt-to-equity at 0.02 shows negligible leverage risk.
- PAT improved sequentially (₹182 Cr. → ₹193 Cr.), showing earnings growth.
- FII holding increased (+0.10%), reflecting foreign investor confidence.
### Limitation
- RSI at 43.1 indicates weak momentum, leaning towards oversold territory.
- MACD negative (-35.6) signals bearish bias.
- Current price (₹4,625) below both DMA 50 (₹4,772) and DMA 200 (₹4,899), showing technical weakness.
- Intraday volume (13,754) below weekly average (18,589), limiting liquidity.
- PEG ratio (3.45) suggests expensive growth-adjusted valuation.
- 52-week index at 10.8% highlights weak relative performance.
### Company Negative News
- DII holding reduced (-0.16%), showing domestic institutional caution.
- Quarterly profit variation (-2.64%) reflects mild earnings pressure.
### Company Positive News
- PAT growth sequentially supports sentiment.
- Dividend yield at 0.76% provides shareholder returns.
- FII holding increased (+0.10%), showing marginal foreign confidence.
### Industry
- Pharma sector benefits from defensive demand and global healthcare growth.
- Industry PE at 31.6 is slightly higher than PFIZER’s P/E (27.8), showing fair valuation relative to peers.
### Conclusion
PFIZER is a moderately strong intraday candidate with solid fundamentals but weak technical momentum. Best suited for disciplined trades between ₹4,600–4,750 with strict stop-loss at ₹4,570. Avoid aggressive positions unless strong breakout volume confirms strength above ₹4,750; risk remains moderate due to weak momentum and limited liquidity.
Would you like me to extend this into a peer benchmarking HTML overlay comparing PFIZER’s intraday setup against Sun Pharma, Dr. Reddy’s, and Cipla for sector-relative positioning?